ST. LOUIS (Sept. 27, 2024) – Two races remain in the 2024 season in the Congruity NHRA Pro Mod Drag Racing Series presented by LearnEV+ and there’s still plenty on the line heading to St. Louis as ...
Unity around our shared principles and common goals is crucial and urgent. The Summit of the Future (September 2024) is a once-in-a-generation opportunity to enhance cooperation on critical challenges ...
Toyota has been considering the Supercars Championship for more than 20 years, the brand said, and has committed to racing in the series for at least five years. Toyota says that it will enter at ...
Logitech certainly has a reputation for long-lasting quality, particularly for its sim racing equipment, so that emphasis on reliability is understandable—though, arguably the company shouldn ...
Personnel from across the Army Reserve met at the Defense Logistics Agency facility for the inaugural Army Reserve Equipment Modernization and Resourcing summit. The two-day event allowed ...
A once-in-a-generation UN summit bringing together countries from around the world marks a critical opportunity for far-reaching agreements on international collaboration for a safer, more sustainable ...
Negotiations continue ahead of the Summit of the Future at UN Headquarters this month, where world leaders will enhance cooperation to tackle critical challenges facing the international community and ...
Sept 10 (Reuters) - Microsoft (MSFT.O), opens new tab held a summit on Tuesday to discuss steps to improve cybersecurity systems, after a faulty software update from CrowdStrike (CRWD.O), opens ...
The third edition of the Global AI Summit (GAIN Summit), organized by the Saudi Data and Artificial Intelligence Authority (SDAIA), kicked off in Riyadh on Tuesday under the patronage of Prince ...
It may sound daunting, but it’s far more economical than actual racing where a racing kart alone can set you back some P250,000, and another P100,000 for safety certified equipment like a racing suit, ...
Sept 9 (Reuters) - Summit Therapeutics (SMMT.O), opens new tab shares soared as much as 75% to a record high on Monday as a study in China showed some lung cancer patients on the company's ...
Summit's lung cancer treatment Ivonescimab outperformed Merck's Keytruda in a Phase III trial. The data were even better than anticipated. In response, analysts hiked their price targets on Summit ...